A comprehensive review of everolimus clinical reports: a new mammalian target of rapamycin inhibitor

As new immunosuppressive agents are introduced to the market, clinicians are faced with the daunting task of sifting through the published literature to decide the value that the agent will add to their own practice. We often must extrapolate information provided through study in other solid-organ t...

Full description

Saved in:

Bibliographic Details
Published in:	Transplantation Vol. 94; no. 7; p. 659
Main Authors:	Gurk-Turner, Cheryle, Manitpisitkul, Wana, Cooper, Matthew
Format:	Journal Article
Language:	English
Published:	United States 15.10.2012
Subjects:	Everolimus Evidence-Based Medicine Graft Rejection - enzymology Graft Rejection - immunology Graft Rejection - prevention & control Graft Survival - drug effects Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Organ Transplantation - adverse effects Patient Selection Risk Assessment Risk Factors Sirolimus - adverse effects Sirolimus - analogs & derivatives Sirolimus - therapeutic use Time Factors TOR Serine-Threonine Kinases - antagonists & inhibitors TOR Serine-Threonine Kinases - metabolism Treatment Outcome
ISSN:	1534-6080, 1534-6080
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!